INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr | ₹373 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
Year | Revenue |
---|---|
Mar2024 | ₹1,081 Cr |
Mar2023 | ₹926 Cr |
Mar2022 | ₹801 Cr |
Mar2021 | ₹411 Cr |
Mar2020 | ₹373 Cr |
How is Revenue of INNOVA CAPTAB Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,081 Cr | 16.72 | |
Mar2023 | ₹926 Cr | 15.72 | |
Mar2022 | ₹801 Cr | 94.94 | |
Mar2021 | ₹411 Cr | 10.00 | |
Mar2020 | ₹373 Cr | - |
Compare Revenue of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,200.1 Cr | 6% | 2.3% | 74.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 6% |
2.3% |
74.9% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses